Cancer clinical outcomes for minority ethnic groups

British Journal of Cancer

Volumn 74, Issue SUPPL. 29, 1996, Pages

  Selby, P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST CANCER; CANCER SURVIVAL; COLORECTAL CANCER; CONFERENCE PAPER; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; ARTICLE; EUROPE; MIDDLE AGED; MINORITY GROUP; MORTALITY; NEOPLASM; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

ADULT; AGED; ETHNIC GROUPS; EUROPE; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MINORITY GROUPS; NEOPLASMS; QUALITY OF LIFE; TREATMENT OUTCOME; UNITED STATES;

EID: 0029790612     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (71)

1. YOUNG JL, RIES LG, POLLACK ES. (1984) Cancer patients survival among ethnic groups in the United States. J of the National Cancer Institute 73; 341-352.
2. MYERS MH & HANKEY BF. (1980) Patient Survival Experience. NIH Publication 80; 2148.
3. AXTELL LM, MYERS MH, SHAMBAUGH EM. (1975) Treatment and survival patterns for black and white cancer patients diagnosed 1955-1964. Department of Health, Education and Welfare (DHEW) Publication No (NIH) 75; 712.
4. AXTELL LM & MYERS MH.(1978) Contrasts in survival of black and white cancer patients 1960-1973. J Natl Cancer Inst. 60; 1209-1215.
5. AXTELL LM, ASIRE AJ, MYERS MH (eds) (1981) Cancer patient survival: Report No 5. NIH Publication No 81; 992.
6. RIES LG, POLLACK ES, YOUNG JL Jr. (1983) Cancer patient survival: Surveillance, Epidemiology and End Results Program 1973-1979. J Natl Cancer Inst. 70; 693-707.
7. METTLIN C, NATARAJAN N, MURPHY GP. (1982) Recent patterns of care of prostate cancer patients in the United States: Results from the surveys of the American College of Surgeons Commission on Cancer. International Advances in Surgical Oncology 5; 277-321.
8. METTLIN C, NATARAJAN N, MITTELMAN A et al. (1982) Management and survival of adenocarcinoma of the rectum in the United States: Results of a national survey by the American College of Surgeons. Oncology 39; 265-273.
9. MURPHY GP, NATARAJAN N, PONTES JE et al. (1982) The national survey of prostate cancer in the United States by the American College Surgeons. J of Urology 127; 928-934.
10. CHRISTOPHERSEN WM AND NEALON NA. (1981) Uterine cancer: A comparative study of black and white women. In Mettlin C, Murphy GP eds. Cancer Among Black Populations: Progress in Clinical and Biological Research Vol 53, New York: Alan R Liss; 185-195.
11. SHAPIRO S, VENET W, STRAX P et al. (1982) Prospects for eliminating racial differences in breast cancer survival rates. Am J of Public Health 72; 1142-1145.
12. KOVI J, VIOLA MV, CONNOLLY CA et al. (1974) Gastric cancer in American negroes. Cancer 34; 765-770.
13. STEINHORN SC, MYERS MH, HANKEY BF et al. (1986) Factors associated with survival differences between black women and white women with cancer of the uterine corpus. Am J of Epidemiology 124; 85-93.
14. WHITE JE, ENTERLINE JP, ALAM Z et al. (1981) Cancer among blacks in the United States: Recognising the problem. In Mettlin C, Murphy GP eds. Cancer Among Black Populations: Progress in Clinical and Biological Research Vol 53, 35-53. Alan R Liss: New York.
15. HOWARD J, HANKEY BF, GREENBERG RS et al (1992) A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer 69: 2349-2360.
16. NEMOTO T, VANA J, NATARAJAN N et al. (1981)Observations on short term and long term surveys of breast cancer by the American College of Surgeons: I Significance of the number of axillary nodes and II Estrogen receptor assay in the US in 1977. International Advances in Surgical Oncology 4; 209-239.
17. FOWLER WC JR, FREEMAN AC, HULKA BS et al. (1984) Delays in cervical cancer treatment: An assessment of patient and provider characteristics. eds Engstrom PF, Anderson PN, Mortenson LE. In Advances in Cancer Control: Epidemiology and Research. Progress in Clinical and Biological Research Vol 156, 265-274. Alan R Liss: New York.
18. POLEDNAK AP. (1986) Breast cancer in black and white women in New York state: Distribution and incidence rates by clinical stage at diagnosis. Cancer 58; 807-815.
19. ELEY JW, HILL HA, CHEN VW, AUSTIN DF, WESLEY MN, MUSS HB, GREENBERG RS, COATES RJ, CORREA P, REDMOND CK et al. (1994) Racial differences in survival from breast cancer: Results of the National Cancer Institute Black/White Cancer Survival Study. J of the Am Medical Association 272; 947-954.
20. HUNTER CP, REDMOND CK, CHEN VW, AUSTIN DF, GREENBERG RS, CORREA P et al. (1993) Breast cancer factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 85; 1129-1137.
21. REYNOLDS P, BOYD PT, BLACKLOW RS, JACKSON JS, GREENBERG RS, AUSTIN DF et al. (1994) Relationship between social ties and survival among black and white breast cancer patients. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiology, Biomarkers & Prevention 3; 253-259.
22. MUSS HB, HUNTER CP, WESLEY M, CORREA P, CHEN VW, GREENBERG RS et al (1992) Treatment plans for black and white women with stage II node positive breast cancer. National Cancer Institute Black/White Cancer Survival Study Experience. Cancer 70; 2460-2467.
23. COATES RJ, BRANSFIELD DD, WESLEY M, HANKEY B, ELEY JW, GREENBERG RS et al. (1992) Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 84; 938-950.
24. COATES RJ, GREENBERG RS, LIU MT, CORREA P, HARLAN LC, REYNOLDS P, FENOGLIO-PREISER CM et al. (1995) Anatomic site distribution of colon cancer by race and other colon cancer risk factors. Diseases of the Colon & Rectum 38; 42-50.
25. MAYBERRY RM, COATES RJ, HILL HA, CLICK LA, CHEN VW, AUSTIN DF et al. (1995) Determinants ofblack/white differences in colon cancer survival. J Natl Cancer Inst. 87; 1686-1693.
26. MUIR CS, NECTOUX J A & STASZEWSKI J. (1991) The epidemiology of prostatic cancer: Geographical distribution and time trends. Acta Oncologica 30; 2: 133-144.
27. ROSS R, BERNSTEIN L, JUDD H et al. (1986) Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst. 76; 1: 45-48.
28. ROSS R, SHIMIZU H, PAGANINI-HILL A et al. (1987) Case control studies of prostate cancer in blacks and whites in Southern California. J Natl Cancer Inst. 78; 5: 869-873 .
29. HAYES RB, LIFF JM, POTTERN LM, GREENBERG RS, SCHOENBERG JB, SCHWARTZ AG, SWANSON GM, SILVERMAN DT, BROWN LM, HOOVER RN et al. (1995) Prostate cancer risk in US blacks and whites with a family history of cancer. International J of Cancer 60; 3: 361-4.
30. AUSTIN J-P, AZIZ H, POTTERS L, THELMO W, CHEN P, CHOI K et al. (1990) Diminished survival of young blacks with adenocarcinoma of the prostate. Am J of Clinical Oncology 13; 6: 465-469.
31. OWEN WL. (1976) Cancer of the prostate: A literature review. Journal of Chronic Diseases 29;89.
32. BURBANK F AND FRAUMENI JF Jr. (1972) US cancer mortality: Non-white predominance. J Natl Cancer Inst. 49; 649-53.
33. LEVINE RL AND WILCHINSKY M. (1979) Adenocarcinoma of the prostate: A comparison of the disease in blacks versus whites. J of Urology 121; 761-2.
34. POLEDNAK AP & FLANNERY JT. (1992) Black vs white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer 70; 2152-2158.
35. JENSEN OM, ESTEVE J, MOLLER H et al. (1990) Cancer in the European Community and its member states. EJC 26; 1167-256.
36. WHEELER S AND SELBY P. (1993) Confronting Cancer-cause and prevention. Penguin Books, London.
37. BERRINO F, SANT M, VERDECCHIA A, CAPOCACCIA R, HAKULINEN T, ESTEVE J (1995). Survival of Cancer Patients in Europe. The EUROCARE Study. IARC Scientific Publication No 132, Lyon.
38. MOINPOUR CM, FEIGL P, METCH B et al. (1989) Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst. 81; 485-495.
39. KORNBLITH AB, ANDERSON J, CELLA DF et al. (1990) Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trials. Oncology 4; 93-101.
40. FINKELSTEIN DM, CASSILETH BR, BONOMI PD et al. (1988) A pilot study of the Functional Living Index - Cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group Study. Am J of Clinical Oncology 11; 630-633.
41. OSOBA D. (1992) The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: organisation and functions. Quality of Life Research 1; 203-211.
42. AARONSON NK AND BECKMANN J. (1987) The Quality of Life of Cancer Patients. EORTC Monograph Series 17; Raven Press: New York.
43. AARONSON NK, VAN DAM FSAM, POLAK CE et al. (1986) Prospects and problems in European psychosocial oncology: a survey of the EORTC Study Group on Quality of Life. J of Psychosocial Oncology 4; 43-53.
44. GANZ PA, BERNHARD J, HURNY C. (1991) Quality of life and psychosocial oncology research in Europe: state of the art. J of Psychosocial Oncology 9; 1-22.
45. GELBER RD AND GOLDHIRSCH A. (1986) A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J of Clinical Oncology 4; 1772-1779.
46. NAYFIELD SG AND HAILEY BJ. (1991) Quality of Life Assessment in Cancer Clinical Trials. Division of Cancer Prevention and Control. National Cancer Institute: Bethesda MD.
47. AMERICAN CANCER SOCIETY. (1991) American Cancer Society's Second Workshop on methodology in behavioural and psychosocial cancer research. Cancer 67.
48. STJERNSWARD J AND TEOH N. (1991) Perspectives on quality of life and the global cancer problem. In Effect of Cancer on Quality of Life. Osoba D (ed). 1-5. CRC Press: Boston.
49. JOHNSON JR AND TEMPLE R. (1985) Food and Drug Administration requirements for approval of new anticancer drug. Cancer Treatment Reports 69; 1155-1159.
50. HENDERSON-JAMES D AND SPILKER B. (1990) An industry perspective. In Quality of Life Assessment in Clinical Trials. Spilker B (ed). 183-192. Raven Press: New York.
51. KIEBERT GM, DE HAES JC, VAN DE VELDE CJ. (1991) The impact of breast conserving treatment and mastectomy on the quality of life of early stage breast cancer patients: a review. J of Clinical Oncology 9; 1059-1070.
52. IRVINE D, BROWN B, CROOKS D et al. (1991) Psychosocial adjustment in women with breast cancer. Cancer 67; 1097-1117.
53. GOLDHIRSCH A, GELBER RD, SIMES RJ et al. (1989) Costs and benefits of adjuvant therapy in breast cancer: a quality adjusted survival analysis. J of Clinical Oncology 7; 36-44.
54. COATES A, GEBSKI V, BISHOP JF et al. (1987) Improving the quality of life during chemotherapy for advanced breast cancer: a comparison of intermittent and continuous treatment strategies. New England J of Medicine 317; 1490-1495.
55. VAN HOLTEN-VERZANTVOORT AT, ZWINDERMAN AH, AARONSON NK et al. (1991) The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast disease. EJC 27; 544-549.
56. GEDDES DM, DONES L, HILL E et al. (1990) Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomised trial. EJC 26; 484-492.
57. GANZ PA, LEE JJ, SIAU J. (1991) Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer 67; 3131-3135.
58. SUGARBAKER PH, BAROFSKY I, ROSENBERG SA et al. (1982) Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery 91; 17-23.
59. VELDHUYZEN VAN ZANTEN SJ. (1991) Quality of life as outcome measures in randomised clinical trials: an overview of three general medical journals. Controlled Clinical Trials 12; 234S-242S.
60. O'YOUNG J AND MCPEEK B. Quality of life variables in surgical trials. J of Chronic Diseases 40; 513-522
61. DEYO RA AND PATRICK DL. (1989) Barriers to the use of health status measures in clinical investigation, patient care and policy research. Medical Care 27; S254-268.
62. YANCIK R, EDWARDS BK, YATES JW. (1989) Assessing the quality of life of cancer patients: practical issues in study implementation. J of Psychosocial Oncology 7; 598-74.
63. SCHIPPER H, CLINCH J, MCMURRAY A et al. (1984) Measuring the quality of life of cancer patients. The Functional Living Index - Cancer: development and validation. J of Clinical Oncology 2; 472-483.
64. SELBY P, CHAPMAN J W, BOYD N F. (1984) Methods of evaluating quality of life in cancer patients. BJC 49; 386-387.
65. PRIESTMAN T AND BAUM M. (1976) Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 1; 899-900.
66. AARONSON NK, AHMEDZAI S, BERGMAN B et al. (1993) The European Organisation for Research and Treatment of Cancer QLQ-C30; a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 85; 5: 365-375.
67. SPRANGERS MAG, CULL A, BJORDAL K. (1993) The European Organisation for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Quality of Life Research 2; 287-295.
68. AARONSON NK, CULL A, KAASA S et al (1995) The European Organisation for Research and Treatment of Cancer modular approach to quality of life assessment in oncology: an update. In Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edition. Ed Spilker B. Raven Press:New York. In press.
69. MAGUIRE P AND SELBY P. (1989) Assessing the quality of life in cancer patients. BJC 60; 437-440.
70. DE HAES JCJM, VAN KNIPPENBERG FCE, NEIJT JP. (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. BJC 62; 1034-1038.
71. ZIGMOND A AND SNAITH P. (1983) The Hospital Anxiety and Depression Questionnaire. Acta Scand Psychiat 67; 361-368.